Predominance of Candida tropicalis bloodstream infections in a Singapore teaching hospital

Medical Mycology

Volumn 45, Issue 5, 2007, Pages 435-439

  Chai, Yi Ann Louis ^a   Wang, Yue ^b   Khoo, Ai Leng ^a   Chan, Fong Yee ^b   Chow, Carol ^a   Kumarasinghe, Gamini ^a   Singh, Kamaljit ^a,c   Tambyah, Paul Ananth ^a,d  

^a NATIONAL UNIVERSITY HOSPITAL   (Singapore)

^b INSTITUTE OF MOLECULAR AND CELL BIOLOGY   (Singapore)

^c RUSH UNIVERSITY MEDICAL CENTER   (United States)

^d NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Candida tropicalis; Epidemiology; Singapore

Indexed keywords

ANTIBIOTIC AGENT; FLUCONAZOLE;

ADOLESCENT; ADULT; AGED; ARTICLE; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; CANDIDEMIA; CHILD; CONTROLLED STUDY; DRUG EXPOSURE; FEMALE; FUNGAL STRAIN; HOSPITAL INFECTION; HUMAN; INFANT; INFECTION RISK; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MOLECULAR EPIDEMIOLOGY; MORTALITY; RISK FACTOR; SINGAPORE; TEACHING HOSPITAL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIFUNGAL AGENTS; CANDIDA; CANDIDA TROPICALIS; CANDIDIASIS; CHILD; CHILD, PRESCHOOL; DNA, FUNGAL; EPIDEMIOLOGY, MOLECULAR; FEMALE; FLUCONAZOLE; FUNGEMIA; HOSPITALS, TEACHING; HUMANS; INFANT; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; RANDOM AMPLIFIED POLYMORPHIC DNA TECHNIQUE; SINGAPORE;

CANDIDA; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS;

EID: 34547584830     PISSN: 13693786     EISSN: 14602709     Source Type: Journal    
DOI: 10.1080/13693780701385868     Document Type: Article

References (20)

1. Wisplinghoff, H., Bischoff, T. and Tallent, SM (2004) Nosocomial bloodstream infections in US hospitals: Analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis, 39, pp. 309-317.
2. Girmenia, C. and Martino, P. (2001) Fluconazole and changing epidemiology of candidemia. Clin Infect Dis, 27, pp. 232-233.
3. Pfaller, MA, Jones, RN and Doern, GV (2000) Bloodstream infections due to Candida species: SENTRY antimicrobial surveillance programme in North America and Latin America, 1997-1998. Antimicrob Agents Chemother, 44, pp. 747-751.
4. Blumberg, HM, Jarvis, WR and Soucie, JM (2001) Risk factors for Candida bloodstream infections in surgical intensive care unit patient: The NEMIS prospective multicenter study. Clin Infect Dis, 33, pp. 177-186.
5. Marchetti, Bille, J. and Fluckier, U. (2004) Fungal infection network of Switzerland. Epidemiology of candidemia in Swiss tertiary care hospitals: Secular trends 1991-2000. Clin Infect Dis, 38, pp. 311-320.
6. Matar, MJ, Otrosky-Zeichner, L. and Paetznick, VL (2003) Correlation between E-test, disk diffusion and microdilution methods for antifungal susceptibility testing of fluconazole and voriconazole. Antimicrob Agents Chemother, 47, pp. 1647-1651.
7. (2002) Reference method for broth microdilution antifungal susceptibility of yeasts. Wayne, PA
8. Roilides, E., Farmaki, E. and Evdoridou, J. (2003) Candida tropicalis in a neonatal intensive care unit: Epidemiologic and molecular analysis of an outbreak of infection with an uncommon neonatal pathogen. J Clin Microbiol, 41, pp. 735-741.
9. Abi-Said, D., Anaissie, E. and Uzum, O. (1997) The epidemiology of hematogenous candidiasis by different Candida species. Clin Infect Dis, 24, pp. 1122-1128.
10. Oon, LL and Yeo, MG. (2003) Fluconazole susceptibility of Candida species in Singapore by disc diffusion test. Ann Acad Med Singapore, 31, pp. 497-501.
11. Foongladda, S., Sakulmaiwatana, P., Petlum, P. and Vamprapar, N. (1987) Candida species, genotype and antifungal susceptibility of Candida isolates from blood samples of patients at the largest tertiary care hospital in Thailand during 1999-2002. J Med Assoc Thai, 2004, pp. 92-99.
12. Matthews, MS, Samuel, P. and Suresh, M. (2001) Emergence of Candida tropicalis as the major cause of fungaemia in India. Mycoses, 44, pp. 278-280.
13. Al-Jasser, AM and Elkhizzi, NA. (2004) Distribution of Candida species among bloodstream isolates. Saudi Med J, 25, pp. 566-569.
14. Weinberger, M., Leibovici, L., Perez, S. and Samra, Z. (2005) Characteristics of candidemia with Candida albicans compared with non-albicans Candida species and predictors of mortality. J Hosp Infect, 61, pp. 146-154.
15. Chen, YC, Chang, SC, Luh, KT and Hsieh, WC. (2003) Stable susceptibility of Candida blood isolates to fluconazole despite increasing use during past 10 years. J Antimicrob Chemother, 52, pp. 71-77.
16. Takakura, S., Fujihara, N. and Saito, T. (2004) National surveillance of species distribution in blood isolates of Candida species in Japan and their susceptibility to six anti-fungal agents including voriconazole and micafungin. J Antimicrob Chemother, 53, pp. 283-289.
17. Yang, YL, Ho, YA, Cheng, HH and Lo, HJ (2005) Distribution and susceptibility to amphotericin B and fluconazole of Candida spp. isolated from Taiwan. Epidemiol Infect, 133, pp. 325-330.
18. Berrouane, YF, Herwaldt, LA and Pfaller, MA. (1999) Trends in antifungal use and epidemiology of nosocomial yeast infections in a university hospital. J Clin Microbiol, 37, pp. 531-537.
19. Myoken, Y., Kyo, T. and Kohara, T. (2004) Clinical significance of breakthrough fungemia caused by azole-resistant Candida tropicalis in patients with hematologic malignancies. Haematologica, 89, pp. 378-380.
20. Pfaller, MA and Diekema, DJ. (2007) Epidemiology of invasive candidiasis: A persistent public health problem. Clin Microbiol Rev, 20, pp. 133-163.